Results 131 to 140 of about 54,799 (219)
ABSTRACT Background and Aims Elevated blood glucose levels in diabetes and prediabetes contribute to vascular inflammation and may increase the risk of major adverse cardiac events (MACE). We sought to evaluate the association between different glycemic statuses and 12‐month MACE in patients undergoing elective percutaneous coronary intervention (PCI ...
Ali Hosseinsabet +7 more
wiley +1 more source
1.11 Prevalence of Metabolic Alterations In Hypertensive Patients with Stable vs Unstable Angina [PDF]
Francesco Paneni +7 more
openalex +1 more source
The Physiology of Lived Experience: And then there was one – the story of a radical nephrectomy
Experimental Physiology, EarlyView.
Michael J. Shattock
wiley +1 more source
Abstract Aims Retatrutide, a novel synthetic molecule, is a triple agonist activating the glucose‐dependent insulinotropic polypeptide, glucagon‐like peptide‐1 and glucagon receptors. The TRIUMPH clinical development program evaluates its safety and efficacy concurrently for the treatment of obesity and two related complications—obstructive sleep apnea
Kathryn Giblin +8 more
wiley +1 more source
There had been shown a normalizing effect of THz radiation of MEAS (molecular emission and absorption spectrum) of 400 GHz nitrogen oxide occurrence on aggregation parameters of thrombocytes in patients with unstable angina at in vitro conditions.
Vyacheslav F. Kirichuk +1 more
doaj
Effect of Cardiac Rehabilitation Therapy Combined with WeChat Platform Education on Patients with Unstable Angina Pectoris after PCI [PDF]
Bin Wang +8 more
openalex +1 more source
Abstract Aims This study examined rates of metabolic/bariatric surgery (MBS) among adults with type 2 diabetes and obesity (T2D + O). The study also compared glucose‐lowering medication (GLM) use, costs, comorbidities and medical events for individuals with T2D + O who underwent MBS (cases) to those who did not have MBS (controls).
Kristina S. Boye +4 more
wiley +1 more source
Trained Immunity and Cardiovascular Risk: An Immunological Perspective
ABSTRACT Systemic inflammation is a key driver of atherogenesis and its complications. While anti‐inflammatory therapies targeting pathways such as IL‐1β and IL‐6 have shown promise in established atherosclerotic cardiovascular disease (ASCVD), potential systemic effects raise concerns about immune suppression and infection, underscoring the need for ...
Katherine A. Boden +3 more
wiley +1 more source
The Effects of Xuefu Zhuyu and Shengmai on the Evolution of Syndromes and Inflammatory Markers in Patients with Unstable Angina Pectoris after Percutaneous Coronary Intervention: A Randomised Controlled Clinical Trial [PDF]
Jie Wang +10 more
openalex +1 more source

